A nationwide survey of pharmacists' perception of pharmacogenetics in the context of a clinical decision support system containing pharmacogenetics dosing recommendations. (February 2017)

• Record Type: Journal Article
• Authors: Bank, Paul CD; Swen, Jesse J; Guchelaar, Henk-Jan
• Is Part Of: Pharmacogenomics. Volume 18:Number 3(2017)
• Page Start: 215
• Page End: 225
• Publication Date: 2017-02
• Subjects: clinical practice -- pharmacists -- pharmacogenetics; Pharmacogenomics -- Periodicals; 615.1
• DOI: 10.2217/pgs-2016-0138
• Languages: English
• ISSNs: 1462-2416

Abstract

Aim: To benchmark Dutch pharmacists knowledge, experience and attitudes toward pharmacogenetics (PGx) with a specific focus on the effects of awareness of the Dutch Pharmacogenetics Working Group guidelines.Methods: A web-based survey containing 41 questions was sent to all certified Dutch pharmacists.Results: A total of 667 pharmacists completed the survey (18.8%). Virtually all responders believed in the concept of PGx (99.7%). However, only 14.7% recently ordered a PGx test (≤6 months), 14.1% felt adequately informed and 88.8% would like to receive additional training on PGx. Being aware of the Dutch Pharmacogenetics Working Group guidelines did not have any significant effect on knowledge or adoption of PGx.Conclusion: Dutch pharmacists are very positive toward PGx. However, test adoption is low and additional training is warranted.